Compare Kinross Gold Corporation (KGC) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kinross Gold Corporation vs Nuwellis Inc — how do they compare? Kinross Gold Corporation trades at $23.74 (market cap $27.62B), while Nuwellis Inc trades at $0.69 (market cap $2.20M). The key difference: Kinross Gold Corporation is far larger — about 12554.5× Nuwellis Inc's market cap, and Kinross Gold Corporation pays a 0.69% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kinross Gold Corporation for 53 Days and Nuwellis Inc for 26 Days on average.
| KGC | NUWE | |
|---|---|---|
Market Cap | $27.62B | $2.20M |
Volume | 6,347,266 | 121,544 |
Sector | Basic Materials | Health |
52-Week High | $38.06 | $146.65 |
52-Week Low | $22.47 | $0.68 |
Typical Hold Time | 53 Days | 26 Days |
Enterprise Value | $25.70B | -$1.52M |
Dividend Yield | 0.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
KGC trades at $23.34, up 0.69% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company shows strong fundamentals, with Q2 2026 EPS beating estimates at $0.71 and robust cash flow growth, though recent news highlights production guidance cuts and legal investigations. Valuation ratios remain attractive, with a P/E of 8.87 and EV/EBITDA of 4.59.
The outlook is mixed: strong earnings and cash flow support upside to the $38.80 consensus price target, but risks include cost pressures, production setbacks, and legal scrutiny. Analyst sentiment is bullish with 59% buy ratings, but investors should weigh operational execution against macroeconomic gold price volatility.
NUWE trades at $0.689, down 0.25% with a bearish technical signal despite oversold RSI readings. The company shows promising revenue growth (14% YoY in Q2 2026) and strong gross margins (69.69%), but faces significant profitability challenges with a -125.63% net income margin and negative cash flow. Recent news highlights console adoption growth and strategic expansions in pediatric care.
While NUWE's valuation metrics appear attractive (P/E 0.03, P/S 0.01), the company's persistent losses and negative cash flow present substantial risk. Analyst sentiment is mixed with a 50/50 buy/hold split. The stock offers speculative potential if management can achieve profitability, but requires careful risk assessment given current financial challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kinross Gold Corporation
Kinross Gold is a Canada-based senior gold producer, producing roughly 2.4 million gold equivalent ounces in 2020. The company had 30 million ounces of proven and probable gold reserves and 59 million ounces of silver reserves at the end of 2020. It operates mines and focuses its greenfield and brownfield exploration in the Americas, West Africa, and Russia. The company has historically used acquisitions to fuel expansion into new regions and production growth.
Read more on KGC →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
